FDA Settles Allegations Of Uneven Blood Treatment Standards
The U.S. Food and Drug Administration has settled a pharmaceutical company's lawsuit in D.C. federal court accusing the agency of subjecting the company's blood-clotting medication to costly clinical trials and higher...To view the full article, register now.
Already a subscriber? Click here to view full article